\n Pressmeddelande
\n \u2014
\n19 Maj 2026 14:39<\/p>\n
Dela<\/p>\n
\n L\u00e4nk kopierad!\n <\/p>\n
<\/p>\n Ladda ner Philips-led consortium selected through Karolinska University Hospital-led Region Stockholm tender to deliver advanced remote monitoring for complex patients<\/p>\n Stockholm, Sweden \u2013 Vingmed, a Nordic medical technology company, today announced that a consortium composed of Philips, Vingmed and Cuviva has been selected to support Region Stockholm\u2019s hospital-at-home initiative, enabling hospital-level care to be delivered in patients\u2019 homes across the region. The consortium was selected through a tender led by Karolinska University Hospital for an advanced remote-monitoring program serving patients with complex or chronic conditions.<\/p>\n The up to eight-year agreement will support care for more than 2 million people in Region Stockholm and represents the Region\u2019s first region-wide hospital-at-home initiative, designed to safely extend hospital-led care into patients\u2019 homes through a coordinated, multi-partner model. By combining advanced remote-monitoring technologies with digitally connected care pathways, the program enables patients across Region Stockholm to receive high-quality care at home while helping reduce pressure on hospitals and clinical staff throughout the region.<\/p>\n Delivering hospital-level care at home across Region Stockholm<\/p>\n Through this initiative, hospitals within Region Stockholm will be able to monitor patients with complex or chronic conditions safely and continuously in their homes, by enabling hospital-led clinical oversight through digital connected care. Many of these patients require continuous monitoring of key clinical parameters, including waveform data such as ECG, blood pressure, respiratory rate, and oxygen saturation. This data will be securely available in near real time to healthcare professionals across hospital and primary care settings throughout the region.<\/p>\n The solution also enables direct patient-clinician interaction through assigned care pathways, video consultations, and secure chat functionality, while tracking a wide range of vital signs to support ongoing assessment and early detection of clinical deterioration.<\/p>\n Implemented as a region-wide program, the initiative will serve patients across the greater Stockholm area and directly support Region Stockholm\u2019s healthcare priorities \u2013 responding to rising demand from an ageing population, addressing workforce shortages, and ensuring equitable access to high-quality care in both urban and remote communities.<\/p>\n Accelerating a new era of connected care at regional scale<\/p>\n The consortium brings together Philips, Vingmed and Cuviva \u2013 working alongside leading sensor and wearable technology providers \u2013 to deliver an advanced, patient-centered hospital-at-home solution at a regional scale.<\/p>\n Philips contributes its global expertise in patient monitoring, interoperability, and data integration. Vingmed, a Nordic healthcare technology specialist, is responsible for the clinical measurement devices in the home \u2013 including ECG, blood pressure and pulse oximetry \u2013 and for the deployment and lifecycle management of this equipment across the region. Cuviva serves as the core technology provider, delivering a secure, advanced and fully integrated IT platform that enables structured, scalable hospital-at-home care through digital monitoring, real-time communication, and seamless integration with the hospitals\u2019 digital infrastructure.<\/p>\n Together, the consortium will support Region Stockholm in realizing its vision for the future of care: extending hospital-level oversight safely into the home across the region to improve patient outcomes while easing the burden on clinicians and hospital infrastructure.<\/p>\n A model for the future of healthcare<\/p>\n \u201cThis collaboration represents a shift in how we deliver and experience healthcare in Sweden,\u201d said Julia Strandberg, Chief Business Leader, Connected Care at Philips. \u201cTogether with our consortium partners, we\u2019re combining digital innovation, clinical expertise, and remote monitoring to reach more patients, ease pressure on healthcare systems, and create a scalable model for connected, sustainable, patient-centered care across Europe.\u201d<\/p>\n \u201cFor Vingmed, this is a defining moment,\u201d said Robert Lindesj\u00f6, CEO of Vingmed Sweden. \u201cHospital-at-home only works if the clinical data sent from the patient\u2019s living room is as trustworthy as the data generated in a hospital ward. Region Stockholm and Karolinska are setting the standard for what advanced care in the home can look like, and we are honored to contribute the clinical measurement layer that makes it possible. Bringing hospital-grade ECG, blood pressure and pulse oximetry into thousands of homes \u2013 with the service, training and lifecycle support to match \u2013 is exactly the kind of work Vingmed has built our organization around for more than five decades. Together with Philips and Cuviva, we are turning a long-held ambition for Swedish healthcare into everyday reality.\u201d<\/p>\n About Vingmed<\/p>\n Vingmed is a Nordic medical technology company specializing in advanced clinical solutions across cardiology, neurology, intensive care, and connected care. Founded in Norway in 1968, Vingmed today operates across Sweden, Norway, Denmark and Finland, partnering with leading international manufacturers to deliver high-quality medical devices and digital health solutions to hospitals and care providers throughout the region. Within hospital-at-home and remote patient monitoring, Vingmed provides validated clinical measurement technology \u2013<\/p>\n including ECG, blood pressure and pulse oximetry, together with deployment, training, technical service and lifecycle management. www.vingmed.se<\/a><\/p>\n About Royal Philips<\/p>\n Royal Philips (NYSE: PHG, AEX: PHIA) is a leading health technology company focused on improving people\u2019s health and well-being through meaningful innovation. Philips\u2019 patient- and people-centric innovation leverages advanced technology and deep clinical and consumer insights to deliver personal health solutions for consumers and professional health solutions for healthcare providers and their patients in the hospital and the home. Headquartered in the Netherlands, the company is a leader in diagnostic imaging, ultrasound, image-guided therapy, monitoring and enterprise informatics, as well as in personal health. Philips generated 2023 sales of EUR 18.2 billion and employs approximately 68,700 employees with sales and services in more than 100 countries. News about Philips can be found at www.philips.com\/newscenter. <\/a><\/p>\n About Cuviva<\/p>\n Cuviva is a Swedish digital health company providing a scalable Hospital at Home platform that connects patients, caregivers and healthcare professionals. Its platform supports continuous, personalised and proactive care for people living at home and is used across hospital at home and remote patient monitoring programmes in Northern Europe. Cuviva\u2019s platform is MDR Class IIa certified and validated by the British Standards Institution (BSI). www.cuviva.com<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"Pressmeddelande \u2014 19 Maj 2026 14:39 Dela L\u00e4nk kopierad! Ladda ner Philips-led consortium selected through Karolinska University Hospital-led…\n","protected":false},"author":2,"featured_media":86139,"comment_status":"","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"footnotes":"","_share_on_mastodon":"0"},"categories":[83],"tags":[45362,666,4009,131,132],"class_list":["post-86138","post","type-post","status-publish","format-standard","has-post-thumbnail","category-stockholm","tag-hospital-at-home","tag-partnerships","tag-press-releases","tag-stockholm","tag-sweden"],"share_on_mastodon":{"url":"","error":""},"_links":{"self":[{"href":"https:\/\/www.europesays.com\/dk\/wp-json\/wp\/v2\/posts\/86138","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.europesays.com\/dk\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.europesays.com\/dk\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/dk\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/dk\/wp-json\/wp\/v2\/comments?post=86138"}],"version-history":[{"count":0,"href":"https:\/\/www.europesays.com\/dk\/wp-json\/wp\/v2\/posts\/86138\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/dk\/wp-json\/wp\/v2\/media\/86139"}],"wp:attachment":[{"href":"https:\/\/www.europesays.com\/dk\/wp-json\/wp\/v2\/media?parent=86138"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.europesays.com\/dk\/wp-json\/wp\/v2\/categories?post=86138"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.europesays.com\/dk\/wp-json\/wp\/v2\/tags?post=86138"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}
\n<\/a> <\/p>\n